These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5199396)

  • 41. Stability of nitroglycerin in intravenous admixtures.
    Klamerus KJ; Ueda CT; Newton DW
    Am J Hosp Pharm; 1984 Feb; 41(2):303-5. PubMed ID: 6422753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Compatibility of verapamil hydrochloride injection in commonly used large-volume parenterals.
    Cutie MR; Lordi NG
    Am J Hosp Pharm; 1980 May; 37(5):675-6. PubMed ID: 7386476
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The right solution: mixing I.V. drugs thoroughly.
    Motz-Harding E; Good F
    Nursing; 1985 Feb; 15(2):62-4. PubMed ID: 3844125
    [No Abstract]   [Full Text] [Related]  

  • 44. Information program.
    Donn R
    Hospitals; 1970 Sep; 44(17):78-82. PubMed ID: 5451677
    [No Abstract]   [Full Text] [Related]  

  • 45. Information program.
    Donn R
    Hospitals; 1970 Sep; 44(17):78 passim. PubMed ID: 5451676
    [No Abstract]   [Full Text] [Related]  

  • 46. Procedures for handling intravenous additives. The nursing team approach.
    Paoloni CU
    Hosp Manage; 1969 Sep; 108(3):12-22. PubMed ID: 5809799
    [No Abstract]   [Full Text] [Related]  

  • 47. Influence of compounding on sterility and stability of drugs.
    Hardee GE
    J Am Vet Med Assoc; 1994 Jul; 205(2):224-5. PubMed ID: 7928582
    [No Abstract]   [Full Text] [Related]  

  • 48. Parenteral water-in-oil emulsions as adjuvants.
    Lazarus J; Lachman L
    Bull Parenter Drug Assoc; 1967; 21(5):184-96. PubMed ID: 6073108
    [No Abstract]   [Full Text] [Related]  

  • 49. Solution additive chemical incompatibility study.
    Parker EA
    Am J Hosp Pharm; 1967 Aug; 24(8):434-9. PubMed ID: 6075728
    [No Abstract]   [Full Text] [Related]  

  • 50. ASHP--hospital intravenous admixture program certification.
    Turco S
    Hosp Pharm; 1978 Jun; 13(6):306, 356. PubMed ID: 10307642
    [No Abstract]   [Full Text] [Related]  

  • 51. Formulation of a parenteral solution of acetylcronycinium perchlorate: a soluble pro-drug of the antitumor agent acronycine.
    Huang CH; Kreilgård B; Repta AJ
    Bull Parenter Drug Assoc; 1976; 30(1):1-12. PubMed ID: 1252651
    [No Abstract]   [Full Text] [Related]  

  • 52. Beyond-use dating of parenteral nutrient admixtures.
    Newton DW
    Nutrition; 1998 Jan; 14(1):58-9. PubMed ID: 9437686
    [No Abstract]   [Full Text] [Related]  

  • 53. IV additive service.
    McLemore RA
    Hospitals; 1971 Mar; 45(6):96-8. PubMed ID: 5547690
    [No Abstract]   [Full Text] [Related]  

  • 54. Development of an IV admixture program in a 167-bed hospital.
    Wyatt BK
    Hosp Pharm; 1975 Jun; 10(6):225-9. PubMed ID: 10237880
    [No Abstract]   [Full Text] [Related]  

  • 55. Compatibility and stability of dobutamine hydrochloride with large-volume parenterals and selected additives.
    Kirschenbaum HL; Aronoff W; Piltz GW; Perentesis GP; Cutie AJ
    Am J Hosp Pharm; 1983 Oct; 40(10):1690-1. PubMed ID: 6638033
    [No Abstract]   [Full Text] [Related]  

  • 56. The control bottle.
    Raymond JA
    N Z Med J; 1969 Aug; 70(447):88-90. PubMed ID: 5258886
    [No Abstract]   [Full Text] [Related]  

  • 57. [Special problems in the development of modern infusion solutions].
    Frank P
    Mitt Dtsch Pharm Ges Pharm Ges DDR; 1970 Mar; 40(3):77-88. PubMed ID: 5467832
    [No Abstract]   [Full Text] [Related]  

  • 58. II. Use of time-sharing to generate master formulas.
    Fisher MP; Stocker B; Beikman D; Volodka A
    Bull Parenter Drug Assoc; 1973; 27(4):168-72. PubMed ID: 4726571
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacists and nurses benefit from an I.V. additive program.
    Ragland JB; Knoll KR
    Hospitals; 1968 Aug; 42(16):136-40. PubMed ID: 5666020
    [No Abstract]   [Full Text] [Related]  

  • 60. Quality assurance in I.V. admixture programs.
    Turco SJ
    Hosp Pharm; 1979 Jun; 14(6):307, 311-3. PubMed ID: 10242204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.